Challenges and Perspectives on MDMA-Assisted Therapy

5min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

This chapter explores the changing attitudes towards psychedelics, especially MDMA-assisted therapy for PTSD. It addresses the growing public support for these treatments alongside the challenges posed by clinical trial methodologies and FDA regulations, setting the stage for insights from trial participants.

Military veterans are unlikely collaborators with the psychedelic counterculture. The two groups’ efforts are being tested this month, when the FDA is poised to announce whether or not it’ll approve MDMA for PTSD.

This episode was reported and produced by Haleema Shah, edited by Lissa Soep and Matt Collette, fact-checked by Laura Bullard, engineered by Andrea Kristinsdottir and Rob Byers, and hosted by Sean Rameswaram. It’s the second in a series supported with a grant from the Ferriss–UC Berkeley Psychedelic Journalism Fellowship.

Transcript at vox.com/today-explained-podcast

Support Today, Explained by becoming a Vox Member today: http://www.vox.com/members

Learn more about your ad choices. Visit podcastchoices.com/adchoices